Jnj sotck.

According to 13 analysts, the average rating for KVUE stock is "Buy." The 12-month stock price forecast is $26.82, which is an increase of 29.63% from the latest price. Price Target. $26.82 (29.63% upside) ... Other symbols: ARM BIRK CAVA GDHG JNJ NXT RIVN. 4 days ago - MarketBeat.Johnson & Johnson. Market Cap. $372B. Today's Change. Current Price. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...JNJ is currently trading at an EV/NTM Revenue of 4.43x, in line with its 3Y mean of 4.62x. Analysts also rate JNJ stock as fair value now, given its capability and reasonable valuation.Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …In depth view into JNJ (Johnson & Johnson) stock including the latest price, news, dividend history, earnings information and financials.

JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Johnson & Johnson Stock Skirts a 52-Week Low. Here’s What’s Ailing Healthcare. By Josh Nathan-Kazis. Oct 24, 2023, 2:14 pm EDT. Share. Resize. Reprints.

Johnson & Johnson (NYSE: JNJ) stock is on the move Tuesday following the release of the company’s earnings report for the third quarter of 2022. The JNJ earnings report starts with adjusted ...Large Cap Pharmaceutical. $360.875B. $94.943B. Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it …J&J’s $40 Billion Kenvue Stock Swap: What You Need to Know. By Andrew Bary. Updated Aug 08, 2023, 4:02 pm EDT / Original Aug 03, 2023, 12:01 am EDTStock analysis for Johnson & Johnson (JNJ:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Separation enhances Company focus on Pharmaceutical and MedTech Research & Development to deliver innovative and differentiated health outcomes Johnson & Johnson shareholders can exchange all, some or none of their shares of Johnson & Johnson common stock for shares of Kenvue Provides Johnson & Johnson …

JNJ stock has seen little change, moving slightly from levels of $155 in early January 2021 to around $150 now, vs. an increase of about 10% for the S&P 500 over this roughly 3-year period.

Johnson & Johnson has increased its dividend for the past 61 consecutive years. When did Johnson & Johnson last increase or decrease its dividend? The most recent change in the company's dividend was an increase of $0.06 on Tuesday, April 18, 2023.

When Johnson & Johnson (JNJ 0.32%) ... 10 stocks we like better than Johnson & Johnson When our award-winning analyst team has a stock tip, it can pay to listen. After all, ...Johnson & Johnson in Focus Johnson & Johnson (JNJ) is headquartered in New Brunswick, and is in the Medical sector. The stock has seen a price change of -11.71% since the start of the year.UNH vs. JNJ - Performance Comparison. In the year-to-date period, UNH achieves a 2.09% return, which is significantly higher than JNJ's -13.26% return. Over the past 10 years, UNH has outperformed JNJ with an annualized return of 23.86%, while JNJ has yielded a comparatively lower 7.46% annualized return. The chart below displays the …Kenvue intends to raise an estimated $5 billion in gross proceeds from an IPO of its common stock. The company is beginning the separation process from parent firm Johnson & Johnson. All the ...Johnson & Johnson is a drug stock for conservative investors. Tipranks lists 14 analysts, only 5 of whom are telling clients to buy it. Johnson & Johnson remains conservative, but that’s no ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

JNJ - Johnson & Johnson Stock quote - CNNMoney.com Markets Tech Media Success Video Johnson & Johnson (NYSE:JNJ) 158.39 Delayed Data As of 4:00pm ET +3.73 / …Johnson & Johnson. Market Cap. $372B. Today's Change. Current Price. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a ...Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed ...Microsoft Corporation Common Stock. $352.60 -0.20 -0.06%. Find the latest dividend history for Johnson & Johnson Common Stock (JNJ) at Nasdaq.com.Nov 20, 2023 · Get step-by-step guidance on investing in Johnson & Johnson stock and learn the ins and outs of this healthcare company. Johnson & Johnson (JNJ 2.4%) is an iconic global healthcare company. It was ... Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected].

Johnson & Johnson analyst ratings, historical stock prices, ... Stock Price Target JNJ. High $ 215.00: Median $ 172.00: Low $ 155.00: Average $ 175.42: Current Price $ 154.66: Related Links: Options;Analyst Forecast. According to 15 analysts, the average rating for JNJ stock is "Buy." The 12-month stock price forecast is $169.07, which is an increase of ...

Discover historical prices for JBLU stock on Yahoo Finance. View daily, weekly or monthly format back to when JetBlue Airways Corporation stock was issued.UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is mid ...NEW BRUNSWICK, N.J., August 16, 2023--Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders ...Johnson & Johnson (JNJ) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund ...JNJ stock analysts called for earnings of $10.33 a share and $97.75 billion in sales. Guidance Snags DHR Stock. Meanwhile, DHR stock toppled 2.7% near 269.40 on disappointing guidance due to light ...JNJ - Johnson & Johnson Stock quote - CNNMoney.com Markets Tech Media Success Video Johnson & Johnson (NYSE:JNJ) 158.39 Delayed Data As of 4:00pm ET +3.73 / +2.41% Today’s Change 144.95...

The initial reaction of the markets was positive. As of 11:50 a.m. Eastern Standard Time on Nov. 12, 2021, the date of the announcement, shares of JNJ were up by about 1.3% for the day.

Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Johnson & Johnson (JNJ.NYSE) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Johnson & Johnson | Nyse: JNJ | Nyse.In early April, when the $8.9bn bankruptcy settlement was first reported, JNJ stock leapt from ~$158, to $163, a gain of 3%. In early March, JNJ stock had hit a two-and-a-half year low of ~$151.0.06%. £157.78B. Medtronic PLC. 0.77%. $105.07B. JNJ | Complete Johnson & Johnson stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Get today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.Nov 12, 2021 · The initial reaction of the markets was positive. As of 11:50 a.m. Eastern Standard Time on Nov. 12, 2021, the date of the announcement, shares of JNJ were up by about 1.3% for the day. Johnson & Johnson (JNJ) stock forecast and price target. Find the latest Johnson & Johnson JNJ analyst stock forecast, price target, and recommendation trends with in-depth analysis from research ...Contact Investor Relations. Questions? Please contact us: 1-800-950-5089 [email protected] the latest Johnson & Johnson (JNJ) stock forecast, 12-month price target, predictions and analyst recommendations.Stock Split Information table; Record Date Pay Out Date Action; May 22, 2001: June 12, 2001: 2 for 1 Split: May 21, 1996: June 11, 1996: 2 for 1 Split: May 19, 1992Get today's JNJ stock price and latest Johnson & Johnson stock news as well as JNJ real-time stock quotes, technical analysis, full financials and more.

21 Jul 2021 ... JNJ shares were trading flat immediately following the announcement. The stock has gained 7.6% since the beginning of this year.The stock price for . Johnson & Johnson (NYSE: JNJ) is $158.38 last updated Today at December 1, 2023 at 11:30 PM UTC. Q Does Johnson & Johnson (JNJ) pay a dividend?200% Stock Dividend: December 19, 1958: January 9, 1959: 2 1/2 for 1 Split: February 23, 1951: March 20, 1951: 5% Stock Dividend: ... At Johnson & Johnson, we promise ...Recently, Johnson & Johnson (JNJ 2.40%) ... If you've been considering this dividend-paying stock for one reason or another, the impending spinoff isn't anything to worry about.Instagram:https://instagram. nyse ccicurrent rate i bondsdish network quotebest penny shares app Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. mtb bank mortgagebest mexican stocks The 19 analysts offering 1 year price forecasts for JNJ have a max estimate of — and a min estimate of —. Analyst rating Based on 23 analysts giving stock ratings to JNJ in the past 3 months.NEW BRUNSWICK, N.J., August 16, 2023-- Johnson & Johnson (NYSE: JNJ) today announced the final exchange ratio for its previously announced split-off exchange offer to Johnson & Johnson shareholders to exchange their shares of Johnson & Johnson for shares of common stock of Kenvue Inc. (NYSE: KVUE) (“Kenvue”) currently held by Johnson & Johnson. toast pos stock August 31, 2023 at 5:59 AM · 5 min read. Johnson & Johnson JNJ provided an updated financial guidance for 2023, following the complete separation of its Consumer Health segment as a new publicly ...Revenue Growth. Between 2017 and 2020, Merck’s revenues grew by about 13%, from around $42.3 billion to $48.0 billion, primarily led by its oncology drug – Keytruda – which saw its sales ...